XML 80 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Net Sales by Product
 12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Net Sales by Product Net sales by product:
The Company operates in a single industry engaging in the commercialization of pharmaceutical products for chronic conditions. Accordingly, the Company’s business is classified as a single reportable segment.
The following table presents net sales by product for each of the years ended December 31 (in thousands):
Year ended December 31,
201920182017
BELBUCA$97,538  $45,988  $26,980  
% of net product sales90.4 %89.5 %77.3 %
Symproic8,061  $—  $—  
% of net product sales7.5 %— %— %
BUNAVAIL2,289  5,422  7,942  
% of net product sales2.1 %10.5 %22.7 %
Net product sales$107,888  $51,410  $34,922  
In March 2020 the company announced it will discontinue marketing of BUNAVAIL in 2020.